Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

894 public trials 110 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005854

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +52 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States

University of South Carolina School of Medicine Columbia, South Carolina, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

NCT00003887

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +123 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

NCT00002553

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +53 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

NCT00003874

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +40 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan

NCT01479387

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Many Locations, Japan

View Trial Details

Completed

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

NCT00038623

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Quality of Life in Younger Leukemia and Lymphoma Survivors

NCT00956475

Conditions: Anxiety Disorder, Anxiety Disorders, Blast Crisis, +87 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

NCT00004075

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00004260

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

PS-341 in Treating Patients With Advanced Cancer

NCT00006362

Conditions: Amyloidosis, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations: Mayo Clinic Rochester, Minnesota, United States

University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions